{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:14:18Z","timestamp":1776510858813,"version":"3.51.2"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A retrospective time series analysis was conducted to compare inpatient fluoroquinolone use when susceptibilities were masked and after susceptibilities were unmasked. Although inappropriate culture-directed prescriptions increased, overall fluoroquinolone usage decreased. Culture-directed therapy was a small part of fluoroquinolone usage; hence, efforts should target empiric use to reduce overall consumption.<\/jats:p>","DOI":"10.1017\/ice.2020.74","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T07:38:13Z","timestamp":1586849893000},"page":"731-733","source":"Crossref","is-referenced-by-count":1,"title":["Selective reporting of fluoroquinolone susceptibility as a stewardship measure is of marginal benefit"],"prefix":"10.1017","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-7125","authenticated-orcid":false,"given":"Geraldine Foo","family":"Ting Ting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-6434","authenticated-orcid":false,"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xier Emily","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Jureen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2353-2651","authenticated-orcid":false,"given":"Dale","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-8309","authenticated-orcid":false,"given":"Natasha","family":"Bagdasarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"S0899823X20000744_ref9","doi-asserted-by":"publisher","DOI":"10.1086\/664757"},{"key":"S0899823X20000744_ref8","doi-asserted-by":"publisher","DOI":"10.3201\/eid1901.120310"},{"key":"S0899823X20000744_ref7","unstructured":"7. Surveillance atlas of infectious diseases. European Centre for Disease Prevention and Control website. http:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Instanceprotect%20$%0Delax%20=$GeneralAtlas. Accessed November 28, 2019."},{"key":"S0899823X20000744_ref5","unstructured":"5. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. US Food & Drug Administration website. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm511530.htm Published 2016. Accessed May 23, 2017."},{"key":"S0899823X20000744_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.11.014"},{"key":"S0899823X20000744_ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00950-16"},{"key":"S0899823X20000744_ref1","doi-asserted-by":"publisher","DOI":"10.1086\/382690"},{"key":"S0899823X20000744_ref10","doi-asserted-by":"publisher","DOI":"10.1086\/664763"},{"key":"S0899823X20000744_ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118"},{"key":"S0899823X20000744_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2014.09.004"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X20000744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T11:00:02Z","timestamp":1589367602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X20000744\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0899823X20000744"],"URL":"https:\/\/doi.org\/10.1017\/ice.2020.74","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]}}}